Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Polatuzumab Vedotin
Polatuzumab Vedotin
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
Polivy 140 mg and 30 mg powder for concentrate for solution for infusion
Updated
SPC
PIL
No
A
Polatuzumab Vedotin
Roche Registration GmbH
Cookies
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Product subject to medical prescription which may not be renewed (A)
